These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26874580)

  • 1. The diversity of circulating neutrophils in cancer.
    Mishalian I; Granot Z; Fridlender ZG
    Immunobiology; 2017 Jan; 222(1):82-88. PubMed ID: 26874580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
    Moses K; Brandau S
    Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasticity of myeloid-derived suppressor cells in cancer.
    Tcyganov E; Mastio J; Chen E; Gabrilovich DI
    Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
    Ostrand-Rosenberg S; Fenselau C
    J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and/or granulocytic myeloid derived suppressor cells.
    Seddon A; Hock B; Miller A; Frei L; Pearson J; McKenzie J; Simcock J; Currie M
    J Dermatol Sci; 2016 Aug; 83(2):124-30. PubMed ID: 27160951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity.
    Tumino N; Besi F; Martini S; Di Pace AL; Munari E; Quatrini L; Pelosi A; Fiore PF; Fiscon G; Paci P; Scordamaglia F; Covesnon MG; Bogina G; Mingari MC; Moretta L; Vacca P
    Front Immunol; 2021; 12():803014. PubMed ID: 35116033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils in cancer.
    Treffers LW; Hiemstra IH; Kuijpers TW; van den Berg TK; Matlung HL
    Immunol Rev; 2016 Sep; 273(1):312-28. PubMed ID: 27558343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-Derived Suppressor Cells.
    Gabrilovich DI
    Cancer Immunol Res; 2017 Jan; 5(1):3-8. PubMed ID: 28052991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?
    Brandau S; Moses K; Lang S
    Semin Cancer Biol; 2013 Jun; 23(3):171-82. PubMed ID: 23459190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).
    Alfaro C; Teijeira A; Oñate C; Pérez G; Sanmamed MF; Andueza MP; Alignani D; Labiano S; Azpilikueta A; Rodriguez-Paulete A; Garasa S; Fusco JP; Aznar A; Inogés S; De Pizzol M; Allegretti M; Medina-Echeverz J; Berraondo P; Perez-Gracia JL; Melero I
    Clin Cancer Res; 2016 Aug; 22(15):3924-36. PubMed ID: 26957562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy.
    Rapoport BL; Steel HC; Theron AJ; Smit T; Anderson R
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.
    Zhou J; Nefedova Y; Lei A; Gabrilovich D
    Semin Immunol; 2018 Feb; 35():19-28. PubMed ID: 29254756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
    Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
    Front Immunol; 2019; 10():1401. PubMed ID: 31275327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil Heterogeneity in Cancer: From Biology to Therapies.
    Lecot P; Sarabi M; Pereira Abrantes M; Mussard J; Koenderman L; Caux C; Bendriss-Vermare N; Michallet MC
    Front Immunol; 2019; 10():2155. PubMed ID: 31616408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance.
    Furumaya C; Martinez-Sanz P; Bouti P; Kuijpers TW; Matlung HL
    Front Immunol; 2020; 11():2100. PubMed ID: 32983165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-related circulating and tumor-associated neutrophils - subtypes, sources and function.
    Shaul ME; Fridlender ZG
    FEBS J; 2018 Dec; 285(23):4316-4342. PubMed ID: 29851227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.
    Dumitru CA; Lang S; Brandau S
    Semin Cancer Biol; 2013 Jun; 23(3):141-8. PubMed ID: 23485549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells and their role in pancreatic cancer.
    Pergamo M; Miller G
    Cancer Gene Ther; 2017 Mar; 24(3):100-105. PubMed ID: 27910857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophils: Need for Standardized Nomenclature.
    McKenna E; Mhaonaigh AU; Wubben R; Dwivedi A; Hurley T; Kelly LA; Stevenson NJ; Little MA; Molloy EJ
    Front Immunol; 2021; 12():602963. PubMed ID: 33936029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among myeloid regulatory cells in cancer.
    Umansky V; Adema GJ; Baran J; Brandau S; Van Ginderachter JA; Hu X; Jablonska J; Mojsilovic S; Papadaki HA; Pico de Coaña Y; Santegoets KCM; Santibanez JF; Serre K; Si Y; Sieminska I; Velegraki M; Fridlender ZG
    Cancer Immunol Immunother; 2019 Apr; 68(4):645-660. PubMed ID: 30003321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.